LEPTAVOID 2

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

leptospira interrogans serovar hardjoprajitno; leptospira interrogans serovar pomona

Available from:

Schering-Plough Animal Health Limited

INN (International Name):

leptospira interrogans serovar pomona, leptospira borgpetersenii serovar hardjo

Composition:

leptospira interrogans serovar hardjoprajitno 0 vaccine; leptospira interrogans serovar pomona 0 vaccine

Therapeutic area:

Vaccine

Authorization status:

ACVM Registered

Authorization date:

1971-09-15

Patient Information leaflet

(Area for BN / Exp Date )
RESTRICTED VETERINARY MEDICINE
Keep out of reach of children
FOR ANIMAL TREATMENT ONLY
INACTIVATED VACCINE FOR THE ACTIVE IMMUNISATION OF CATTLE, SHEEP, DEER
AND PIGS
AGAINST LEPTOSPIROSIS CAUSED BY SEROVARS POMONA AND HARDJO
500mL (250 doses)
LEPTAVOID
®
2
RESTRICTED VETERINARY MEDICINE
Keep out of reach of children
FOR ANIMAL TREATMENT ONLY
INACTIVATED VACCINE FOR THE ACTIVE IMMUNISATION OF CATTLE, SHEEP, DEER
AND PIGS
AGAINST LEPTOSPIROSIS CAUSED BY SEROVARS POMONA AND HARDJO
500mL (250 doses)
LEPTAVOID
®
2
LEPTAVOID
®
2
Read entire label before use.
Contains inactivated _Leptospira interrogans_ serovars Pomona and
Hardjo antigens in a serum-free
medium.
USES
For the active immunisation of cattle, sheep, deer and pigs against
Leptospirosis caused by _Leptospira _
_interrogans _serovars Pomona and Hardjo and _Leptospira
borgpetersenii_ serovar Hardjo.
The vaccination of healthy cattle before infection will prevent the
urinary shedding for leptospires for at
least 12 months thereby preventing transmission to humans and animals.
Vaccination will not alter the
shedding status of already infected animals.
As with all vaccines, efficacy is based on the immune response of
animals to vaccination. In any animal
population there may be a small number of individuals which fail to
respond fully to vaccination.
Successful vaccination depends upon correct storage and administration
of the vaccine together with the
animal's ability to respond. The level of exposure to challenge,
management issues, health status of
animal, genetic constitution, intercurrent infection, age, nutritional
status, concurrent drug therapy and
stress all affects the level of protection from the disease.
DOSAGE AND ADMINISTRATION
Shake well before use.
Administer a 2mL dose by subcutaneous injection in the anterior half
of the neck with normal aseptic
precautions.
VACCINATION PROGRAMME
If vaccination status is unknown, animals should either be tested as
free from Leptospirosis, or be treated
with an appropriate antibiotic

Summary of Product characteristics

LEPTAVOID 2
100 mL and 500 mL – Label and Carton
A001948
Page 1 of 5
LEPTAVOID 2
30-NOV-22
Label – 100 mL and 500 mL
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
LEPTAVOID
® 2
READ ENTIRE CARTON BEFORE USE.
DIRECTIONS FOR USE
SHAKE WELL BEFORE USE.
DOSAGE: 2 mL dose by subcutaneous injection into the anterior half of
the neck. Refer to carton
for further information including vaccination programme.
STORAGE: Store away from light at 2°C to 8°C. DO NOT FREEZE. Unused
vaccine can be
stored for up to 6 weeks after opening (see carton for storage
conditions).
ACVM No. A001948.
100 ML (50 DOSES)
[500 ML (250 DOSES)]
MSD AH logo
BATCH NO.
EXPIRY
LEPTAVOID 2
100 mL and 500 mL – Label and Carton
A001948
Page 2 of 5
LEPTAVOID 2
30-NOV-22
Carton – 100 mL and 500 mL, Front panel
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
BOVILIS logo
LEPTAVOID
® 2
INACTIVATED VACCINE FOR THE ACTIVE IMMUNISATION OF CATTLE, SHEEP, DEER
AND PIGS AGAINST
LEPTOSPIROSIS CAUSED BY SEROVARS POMONA AND HARDJO.
SUBCUTANEOUS INJECTION
100 ML
[500 ML]
50 doses
2 ML per dose
[250 doses
2 ML per dose]
MSD AH logo
Carton – 100 mL and 500 mL, Back panel
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
BOVILIS logo
LEPTAVOID
® 2
INACTIVATED VACCINE FOR THE ACTIVE IMMUNISATION OF CATTLE, SHEEP, DEER
AND PIGS AGAINST
LEPTOSPIROSIS CAUSED BY SEROVARS POMONA AND HARDJO.
SUBCUTANEOUS INJECTION
100 ML
[500 ML]
50 doses
2 ML per dose
[250 doses
2 ML per dose]
See safety data sheet (SDS) for further information:
www.msd-animal-health.co.nz
_ _
Registered pursuant to the ACVM Act 1997, No. A001948.
See www.foodsafety.govt.nz for registration conditions.
® Registered trademark
© Copyright [year]
Registered to
LEPTAVOID 2
100 mL and 500 mL – Label and Carton
A001948
Page 3 of 5
LEPTAVOID 2
30-NOV-22
SCHERING-PLOUGH ANIMAL HEALTH LTD
33 Whakatiki Street,
Upper Hutt 5018
Phone: [phone]
www.msd-animal-health.co.nz
Barcode
LEPT